Bausch Health Companies Inc (NYSE:BHC)(TSX:BHC) reported on Friday a change in corporate name to Bausch Health Companies Inc from Valeant Pharmaceuticals International Inc.

Effective 16 July, Bausch Health will begin trading as "BHC" on the New York Stock Exchange (NYSE) as well as on the Toronto Stock Exchange (TSX).

In conjunction with the name change, Bausch Health has introduced its new corporate brand visual identity as well as a new corporate web site: http://www.bauschhealth.com.

All entities under the company have separate established brands will continue to operate under the corporate umbrella using their existing names.

According to Bausch Health Companies Inc, its mission is to improve people's lives with its health care products. It develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology.